Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04116658
Title First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma (ROSALIE)
Acronym ROSALIE
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enterome
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.